Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Non-Current Assets: 2020-2023

Historic Non-Current Assets for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $11.5 million.

  • Therapeutics' Non-Current Assets fell 53.37% to $5.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.9 million, marking a year-over-year decrease of 53.37%. This contributed to the annual value of $11.5 million for FY2023, which is 14.56% down from last year.
  • Per Therapeutics' latest filing, its Non-Current Assets stood at $11.5 million for FY2023, which was down 14.56% from $13.5 million recorded in FY2022.
  • Over the past 5 years, Therapeutics' Non-Current Assets peaked at $13.5 million during FY2022, and registered a low of $3.4 million during FY2020.
  • In the last 3 years, Therapeutics' Non-Current Assets had a median value of $11.5 million in 2023 and averaged $10.2 million.
  • As far as peak fluctuations go, Therapeutics' Non-Current Assets soared by 138.65% in 2022, and later fell by 14.56% in 2023.
  • Over the past 4 years, Therapeutics' Non-Current Assets (Yearly) stood at $3.4 million in 2020, then soared by 67.99% to $5.7 million in 2021, then soared by 138.65% to $13.5 million in 2022, then decreased by 14.56% to $11.5 million in 2023.